![Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding | Bain Capital Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding | Bain Capital](https://www.baincapital.com/sites/default/files/news/Areteia_0.png)
Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding | Bain Capital
$1 trillion in U.S. ETF inflows next year? 'It's safe to say that the sun is setting on the mutual-fund era:' Here's what's in store for 2022. - MarketWatch
![BayPine Exceeds Target for Inaugural Private Equity Fund and Raises Approximately $3.0 Billion | Business Wire BayPine Exceeds Target for Inaugural Private Equity Fund and Raises Approximately $3.0 Billion | Business Wire](https://mms.businesswire.com/media/20220908005290/en/1565019/23/BayPine_Logo_CMYK.jpg)